Identification of potential serum markers for nasopharyngeal carcinoma from a xenografted mouse model using Cy-dye labeling combined with three-dimensional fractionation

Proteomics

Volumn 8, Issue 17, 2008, Pages 3605-3620

  Wu, Chih Ching ^a   Peng, Pei Hua ^a   Chang, Ya Ting ^a   Huang, Yu Shan ^a   Chang, Kai Ping ^b   Hao, Sheng Po ^b   Tsang, Ngan Ming ^b   Yeh, Chau Ting ^b   Chang, Yu Sun ^a   Yu, Jau Song ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

DIGE; Nasopharyngeal carcinoma; Tumor marker; Xenograft model

Indexed keywords

BIOLOGICAL MARKER; CARBONATE DEHYDRATASE II; CYANINE DYE; HYDROGEN PEROXIDE; PEROXIREDOXIN; PLASMA PROTEIN; TUMOR MARKER;

ADULT; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FRACTIONATION; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SERUM; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL GEL ELECTROPHORESIS; TWO DIMENSIONAL IN GEL ELECTROPHORESIS; WESTERN BLOTTING; XENOGRAFT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CARBOCYANINES; CARBONIC ANHYDRASE II; CHILD; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT DYES; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM TRANSPLANTATION; PEROXIREDOXINS; PROTEOMICS; TRANSPLANTATION, HETEROLOGOUS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

MUS; MUS MUSCULUS;

EID: 52649177806     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200701034     Document Type: Article

References (65)

1. McDermott, A. L, Dutt, S. N., Watkinson, J. C., The aetiology of nasopharyngeal carcinoma. Clin. Otolaryngol. Allied Sci. 2001, 26, 82-92.
2. Sham, J. S., Choy, D., Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. Br. J. Radiol. 1990, 63, 51-58.
3. Fandi, A., Altun, M., Azli, N., Armand, J. P. et al., Nasopharyngeal cancer: epidemiology, staging, and treatment. Semin. Oncol. 1994, 21, 382-397.
4. Cho, W. C., Nasopharyngeal carcinoma: molecular bio-marker discovery and progress. Mol. Cancer 2007, 6, 1-9.
5. Bertucci, F., Birnbaum, D., Goncalves, A., Proteomics of breast cancer: principles and potential clinical applications. Mol. Cell. Proteomics 2006, 5, 1772-1786.
6. Khwaja, F. W., Nolen, J. D., Mendrinos, S. E., Lewis, M. M. et al., Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers. Proteomics 2006, 6, 6277-6287.
7. Cho, W. C., Yip, T. T., Yip, C., Yip, V. et al., Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling. Clin. Cancer Res. 2004, 10, 43-52.
8. Wei, Y. S., Zheng, Y. H., Liang, W. B., Zhang, J. Z. et al., Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis. Cancer 2008, 112, 544-551.
9. Purohit, S., Podolsky, R., Schatz, D., Muir, A. et al., Assessing the utility of SELDI-TOF and model averaging for serum proteomic biomarker discovery. Proteomics 2006, 6, 6405-6415.
10. Paweletz, C. P., Wiener, M. C., Sachs, J. R., Meurer, R. et al., Surface enhanced laser desorption ionization spectrometry reveals biomarkers for drug treatment but not dose. Proteomics 2006, 6, 2101-2107.
11. Hwang, T. L., Liang, Y., Chien, K. Y., Yu, J. S., Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma. Proteomics 2006, 6, 2259-2272.
12. Chen, C. D., Wang, C. S., Huang, Y H., Chien, K. Y. et al., Overexpression of CLIC1 in human gastric carcinoma and its clinicopathological significance. Proteomics 2007, 7, 155-167.
13. Liao, Q., Zhao, L., Chen, X., Deng, Y. et al., Serum proteome analysis for profiling protein markers associated with carcinogenesis and lymph node metastasis in nasopharyngeal carcinoma. Clin. Exp. Metastasis 2008.
14. Cheng, A. L, Huang, W. G., Chen, Z. C., Peng, F. et al., Identification of novel nasopharyngeal carcinoma biomarkers by laser capture microdissection and proteomic analysis. Clin. Cancer Res. 2008, 14, 435-445.
15. Sun, W., Xing, B., Sun, Y., Du, X. et al., Proteome analysis of hepatocellular carcinoma by two-dimensional difference gel electrophoresis: novel protein markers in hepatocellular carcinoma tissues. Mol. Cell. Proteomics 2007, 6, 1798-1808.
16. Wu, C.C, Chien, K.Y., Tsang, N. M., Chang, K. P. et al., Cancer cell-secreted proteomes as a basis for searching potential tumor markers: nasopharyngeal carcinoma as a model. Proteomics 2005, 5, 3173-3182.
17. van den Bemd, G. J., Krijgsveld, J., Luider, T. M., van Rijswijk, A. L. et al., Mass spectrometric identification of human prostate cancer-derived proteins in serum of xenograft-bearing mice. Mol. Cell. Proteomics 2006, 5, 1830-1839.
18. Yan, J. X., Devenish, A. T., Wait, R., Stone, T. et al., Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli. Proteomics 2002, 2, 1682-1698.
19. Zhou, G., Li, H., DeCamp, D., Chen, S. et al., 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell. Proteomics 2002, 1, 117-124.
20. Faca, V., Pitteri, S. J., Newcomb, L., Glukhova, V. et al., Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J. Proteome Res. 2007, 6, 3558-3565.
21. Misek, D. E., Kuick, R., Wang, H., Galchev, V. et al., A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system. Proteomics 2005, 5, 3343-3352.
22. Kuick, R., Misek, D. E., Monsma, D. J., Webb, C. P. et al., Discovery of cancer biomarkers through the use of mouse models. Cancer Lett. 2007, 249, 40-48.
23. Wang, H., Clouthier, S. G., Galchev, V., Misek, D. E. et al., Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol. Cell. Proteomics 2005, 4, 618-625.
24. Sharpless, N. E., Depinho, R. A. The mighty mouse: genetically engineered mouse models in cancer drug development. Nat. Rev. Drug Discov. 2006, 5, 741-754.
25. Aebersold, R., Anderson, L., Caprioli, R., Druker, B. et al., Perspective: a program to improve protein biomarker discovery for cancer. J. Proteome Res. 2005, 4, 1104-1109.
26. Juan, H. F., Chen, J. H., Hsu, W. T., Huang, S. C. et al., Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human. Proteomics 2004, 4, 2766-2775.
27. Lin, C. T., Chan, W. Y., Chen, W., Huang, H. M. et al., Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lab. Invest. 1993, 68, 716-727.
28. Yu, J. S., Yang, S. D. Phosphorylation/activation of phosphorylase b kinase by cAMP/Ca2(+)-independent, autophosphorylation-dependent protein kinase. Biochem. Biophys. Res. Commun. 1995, 207, 140-147.
29. Wu, C. C., Chen, H. C., Chen, S. J., Liu, H. P. et al., Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes. Proteomics 2008, 8, 316-332.
30. Zweig, M. H., Campbell, G., Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39, 561-577.
31. Hanley, J. A., McNeil, B. J., The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982, 143, 29-36.
32. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 2002, 1, 845-867.
33. Greenough, C., Jenkins, R. E., Kitteringham, N. R., Pirmo-hamed, M. et al., A method for the rapid depletion of albumin and immunoglobulin from human plasma. Proteomics 2004, 4, 3107-3111.
34. Tang, H. Y., li-Khan, N., Echan, L. A., Levenkova, N. et al., A novel four-dimensional strategy combining protein and peptide separation methods enables detection of low-abundance proteins in human plasma and serum proteomes. Proteomics 2005, 5, 3329-3342.
35. Echan, L. A., Tang, H. Y., li-Khan, N., Lee, K. et al., Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 2005, 5, 3292-3303.
36. Gharbi, S., Gaffney, P., Yang, A., Zvelebil, M. J. et al., Evaluation of two-dimensional differential gel electrophoresis for proteomic expression analysis of a model breast cancer cell system. Mol. Cell. Proteomics 2002, 1, 91-98.
37. Quackenbush, J., Microarray data normalization and transformation. Nat. Genet. 2002, 32, 496-501.
38. Fardin, P., Moretti, S., Biasotti, B., Ricciardi, A. et al., Normalization of low-density microarray using external spike-in controls: analysis of macrophage cell lines expression profile. BMC Genomics 2007, 8, 17.
39. Cho, W. C., Yip, T. T., Ngan, R. K., Yip, T. T. et al., ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin. Chem. 2007, 53, 241-250.
40. Wolf, G. T., Wolfe, R. A., Circulating immune complexes in patients with nasopharyngeal carcinoma. Laryngoscope 1990, 100, 302-308.
41. Gregorini, A., Sahin, F. I., Lillington, D. M., Meerabux, J. et al., Gene BR140, which is related to AF10 and AF17, maps to chromosome band 3p25. Genes Chromosomes Cancer 1996, 17, 269-272.
42. Wang, D., Li, Y., Shen, B., A novel erythroid differentiation related gene EDRF1 upregulating globin gene expression in HEL cells. Chin. Med. J. 2002, 115, 1701-1705.
43. Christiansen, M., Jorgensen, C. S., Laursen, I., Hirschberg, D. et al., Protein chemical characterization of Gc globulin (vitamin D-binding protein) isoforms; Gc-1f, Gc-1s and Gc-2. Biochim. Biophys. Acta. 2007, 1774, 481-492.
44. Crow, J. A., Borazjani, A., Potter, P. M., Ross, M. K. Hydrolysis of pyrethroids by human and rat tissues: examination of intestinal, liver and serum carboxylesterases. Toxicol. Appl. Pharmacol. 2007, 221, 1-12.
45. Moore, L. E., Fung, E. T., McGuire, M., Rabkin, C. C. et al., Evaluation of apolipoprotein A1 and posttranslationally modified forms of transthyretin as biomarkers for ovarian cancer detection in an independent study population. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1641-1646.
46. Kozak, K. R., Su, F., Whitelegge, J. P., Faull, K. et al., Characterization of serum biomarkers for detection of early stage ovarian cancer. Proteomics 2005, 5, 4589-4596.
47. Ahmed, N., Oliva, K. T., Barker, G., Hoffmann, P. et al., Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer. Proteomics 2005, 5, 4625-4636.
48. Zhao, C., Annamalai, L., Guo, C., Kothandaraman, N. et al., Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. Neoplasia 2007, 9, 1-7.
49. Ang, I. L, Poon, T. C., Lai, P. B., Chan, A. T. et al., Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J. Proteome Res. 2006, 5, 2691-2700.
50. Goldman, R., Ressom, H. W., bdel-Hamid, M., Goldman, L. et al., Candidate markers for the detection of hepatocellular carcinoma in low molecular weight fraction of serum. Carcinogenesis 2007, 28, 2149-2153.
51. Yoshiura, K., Nakaoka, T., Nishishita, T., Sato, K. et al., Carbonic anhydrase II is a tumor vessel endothelium-associated antigen targeted by dendritic cell therapy. Clin. Cancer Res. 2005, 11, 8201-8207.
52. Kang, S. W., Rhee, S. G., Chang, T. S., Jeong, W. et al., 2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic Implications. Trends Mol. Med. 2005, 11, 571-578.
53. Wood, Z. A., Schroder, E., Robin, H. J., Poole, L. B., Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 2003, 28, 32-40.
54. Kim, H., Lee, T. H., Park, E. S., Suh, J. M. et al., Role of peroxiredoxins in regulating Intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells, J. Biol. Chem. 2000, 275, 18266-18270.
55. Karihtala, P., Mantyniemi, A., Kang, S. W., Kinnula, V. L et al., Peroxiredoxins in breast carcinoma. Clin. Cancer Res. 2003, 9, 3418-3424.
56. Kinnula, V. L, Paakko, P., Soini, Y., Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung. FEBS Lett. 2004, 569, 1-6.
57. Chang, J. W., Jeon, H. B., Lee, J. H., Yoo, J. S. et al., Augmented expression of peroxiredoxin I in lung cancer. Biochem. Biophys. Res. Commun. 2001, 289, 507-512.
58. Noh, D. Y., Ahn, S. J., Lee, R. A., Kim, S. W. et al., Overexpression of peroxiredoxin in human breast cancer. Anticancer Res. 2001, 21, 2085-2090.
59. Kinnula, V. L., Lehtonen, S., Sormunen, R., KaarteenahoWiik, R. et al., Overexpression of peroxiredoxins I, II, III, V,and VI in malignant mesothelioma. J. Pathol. 2002, 196, 316-323.
60. Szuster-Ciesielska, A., Hryciuk-Umer, E., Stepulak, A., Kupisz, K. et al., Reactive oxygen species production by blood neutrophils of patients with laryngeal carcinoma and antioxidative enzyme activity in their blood. Acta Oncol. 2004, 43, 252-258.
61. Manoharan, S., Kolanjiappan, K., Suresh, K., Panjamurthy, K., Lipid peroxidation & antioxidants status in patients with oral squamous cell carcinoma. Indian J. Med. Res. 2005, 122, 529-534.
62. de Cavanagh, E. M., Honegger, A. E. V., Hofer, E., Bordenave, R. H. et al., Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients. Cancer 2002, 94, 3247-3251.
63. Beevi, S. S., Rasheed, M. H., Geetha, A., Evidence of oxidative and nitrosative stress in patients with cervical squamous cell carcinoma. Clin. Chim. Acta 2007, 375, 119-123.
64. Netto, L. E. S., Chae, H. Z., Kang, S. W., Rhee, S. G. et al., Removal of hydrogen peroxide by thiol-specific antioxidant enzyme (TSA) is involved with its antioxidant properties. TSA possesses thiol peroxidase activity. J. Biol. Chem. 1996, 271, 15315-15321.
65. Peskin, A. V., Low, F. M., Paton, L. N., Maghzal, G. J. et al., The high reactivity of peroxiredoxin 2 with H(2)0(2) is not reflected in its reaction with other oxidants and thiol reagents. J. Biol. Chem. 2007, 282, 11885-11892.